Recipharm AB
Recipharm AB
Headquarters Stockholm, Sweden; key sterile/lyophilized bases: Wasserburg, Germany; Monts, France; Masate, Italy
Overview
Recipharm is a global CDMO headquartered in Sweden (17 plants, 8 countries), with North American aseptic capacity provided through the Advanced Bio facility in Watertown, Massachusetts (80,000 sq ft, plasmid DNA/mRNA/nanoparticle preparation + aseptic filling) and a strategic alliance with Exela Pharma Sciences in 2024 (Lenoir, North Carolina, FDA approved, with an annual capacity of over 100 million vials and prefilled syringes, covering ADCs, GLP-1, vaccines). The official website of Recipharm clearly provides cartridges high-speed aseptic filling (complex prescriptions such as high viscosity, liposomes, nanoparticles) and sterile lyophilisation. 2025–2026 Continuous investment to expand US aseptic filling capacity to serve clinical and commercial projects of customers in North America/Europe.